Page results
-
We provide a specialist spinal surgery service including treatment of degenerative spinal conditions, artificial discs, spinal injury, spinal tumours (intra and extra dural, including metastatic disease), scoliosis and syringomyelia.
-
AutoLab is a dual haematology and biochemistry laboratory which operates as a public private partnership between Sonic Healthcare pty (The Doctors Laboratory) and UCLH NHS Foundation Trust Hospitals Laboratories.
-
Autoimmune serology is provided for: Connective tissue diseases, Endocrine diseases, Liver diseases, Rheumatic diseases, Skin diseases, Thyroid diseases.
-
The department has a special interest in sexually transmitted viral infections and viral infections in relation to hepatitis, bone marrow transplants and HIV-related viral resistance.
-
The day surgery unit, comprises of two operating theatres and a ward located on level T2 at University College Hospital.
-
Sterile services provides a complete decontamination service for medical devices.
-
This is a unique service screening women at risk of ovarian cancer due to a strong family history.
-
We run two separate Urogynaecology services at UCH: the Urogynaecology and Pelvic Floor Unit and the Female Pelvic Medicine and Reconstructive Surgery Unit.
-
This patient information offers advice for patients suffering from long COVID regarding a healthy diet and nutrition.
-
At your first visit to UCLH your midwife will discuss birth place options with you and recommend a place of birth.
File results
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0537 - Agency usage for the Occupational Therapy
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0553 - Maternity complaints by ethnicity
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0561 - Birthrate Plus